Background: CD4CD25 T cells play an important role in the induction and maintenance of peripheral self-tolerance. These professional regulatory cells prevent the activation and proliferation of potentially autoreactive T cells that have escaped thymic deletion.
Objective: To investigate the role of CD4CD25 regulatory T cells in children with idiopathic thrombocytopenic purpura (ITP) and correlate their levels with different disease stages, this study was conducted in 45 children (15 controls and 30 cases with ITP); 10 of these patients were in the acute phase (Group I), 10 in the remission phase (Group II), and the remaining 10 in the chronic phase (Group III).
Methods: Studied groups were subjected to the following investigations: complete blood count, erythrocyte sedimentation rate, Coombs test, and flow cytometric analysis of CD4CD25 T lymphocyte count.
Results: There was a highly significant decrease in platelet count and CD4CD25 count in patients of the acute group when compared with remission, chronic, and control groups. There was a significant decrease in CD4CD25 count in the chronic group when compared with remission group. In addition, a significant decrease in CD4CD25 count was found in remission group when compared with the control group. Moreover, there was a positive correlation between CD4CD25 count and platelet count in all the groups; this correlation was significant in the acute group and insignificant in the remission and chronic groups.
Conclusions: Decreased number of CD4CD25 T cells might be one of the mechanisms that cause immune regulation dysfunction in ITP and the count of CD4CD25 T cells is considered to be related to the severity of ITP, as these cells were significantly decreased in the active phase of the disease and increased in the patients at the complete remission phase. Therefore, count of CD4CD25 T cells might be a helpful diagnostic predictor of onset and improvement of ITP in children. Finally, it is suggested that these cells may have therapeutic implications that need further clarification.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MPH.0b013e3181f46b82 | DOI Listing |
Indian J Tuberc
January 2024
Department of Pathology, University College of Medical Sciences and GTB Hospital, Delhi, India.
J Clin Med
October 2023
Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, 20-081 Lublin, Poland.
CD (cluster of differentiation) 69 and CD25 are considered early and late markers of the activation of lymphocytes, respectively. CD25 is a part of the IL-2 receptor and is present on the surface of immune and non-immune cells, with high amounts on activated lymphocytes and regulatory T cells. CD69 is expressed on various types of white blood cells, including newly activated lymphocytes, lymphocytes infiltrating tissues isolated from subjects with chronic auto-inflammatory diseases, several subtypes of memory T cells and regulatory T cells.
View Article and Find Full Text PDFJ Clin Med
February 2023
Department of Dermatology and Venereology, Medical University of Bialystok, Zurawia 14 St., 15-540 Bialystok, Poland.
Studies have shown that osteopontin (OPN) and regulatory T cells play a role in allergic contact dermatitis (ACD), but the mechanisms responsible for their function are poorly understood. The study aimed to determine CD4 T lymphocytes producing intracellular osteopontin (iOPN T cells) and assess the selected T lymphocyte subsets including regulatory T cells in the blood of patients with ACD. Twenty-six patients with a disseminated form of allergic contact dermatitis and 21 healthy controls were enrolled in the study.
View Article and Find Full Text PDFNutrients
January 2023
Department of Pharmacology and Clinical Pharmacy, Master Pharmacy Degree Program, Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta 55252, Indonesia.
Background: Traditionally, Curcuma xanthorriza (CX), black cumin seed (BC), and honey have been used by the Indonesian people as medicinal ingredients to treat various health symptoms. CX extracts and BC have been proven in the laboratory as chemopreventive agents, antioxidants, and immunomodulators. In this study, we developed CX extract, BC oil, and honey into herbal honey preparations (CXBCH) and hypothesized that the preparations show chemopreventive activity.
View Article and Find Full Text PDFStem Cell Investig
December 2022
Department of Orthopaedics, University of Illinois at Chicago, Chicago, IL, USA.
Background: Cell-based and chimerism-based therapies represent a promising approach for tolerance induction in transplantation. We propose a new cell therapy of the created human hematopoietic chimeric cells (HHCC) as an alternative approach to bone marrow (BM)-based therapies in support of solid organ and vascularized composite allotransplantation (VCA). This study aimed to characterize the phenotype, genotype, clonogenic, and tolerogenic properties of HHCC.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!